Bridging the gap: reducing disparities in diabetes care
This initiative brings together the health care sector and other sectors to support innovative approaches to diabetes treatment and management.
November 1, 2019
An estimated 30 million people have diabetes in the U.S.
Vulnerable and underserved populations in our communities are the most affected, with a higher prevalence of both the disease and its related complications. Too often, these individuals do not receive the help they need to effectively manage their diabetes, including addressing other factors that influence their health such as access to healthy foods and safe options for physical activity.
To help improve the health of people living with diabetes, the Merck Foundation is supporting the program partners of Bridging the Gap: Reducing Disparities in Diabetes Care to increase access to high-quality diabetes care and reduce health disparities among vulnerable and underserved communities in the U.S.
Program partners include:
- Alameda County Public Health Department
- Clearwater Valley Hospital and and St. Mary’s Hospitals and Clinics
- La Clínica del Pueblo
- Marshall University
Together, the Bridging the Gap partners are working to:
Build sustainable partnerships between the health care sector and other sectors to address the medical and social factors that influence health.
Redesign health care systems, particularly primary care, to improve the delivery of diabetes care for vulnerable and underserved populations.
Improve health outcomes for individuals with type 2 diabetes through measures such as better glucose and lipid control.
"There is a higher prevalence of diabetes in underserved communities, where many patients do not receive the help they need to effectively manage their health. Through Bridging the Gap, we are working with our partners to promote sustainable improvements in diabetes care for those who need it the most."
Dr. Julie Gerberding, M.D., M.P.H.Chief Patient Officer
Through Bridging the Gap, the Merck Foundation fosters a comprehensive approach to improve diabetes care and outcomes for vulnerable and underserved populations in the U.S. With $16 million in funding from the Foundation over five years (2017-2021), Bridging the Gap supports multifaceted diabetes programs in selected communities around the country. Working with the National Program Office at the University of Chicago, the Foundation is supporting a comprehensive cross-site evaluation, to assess the impact of this initiative, with a goal of promoting best practices in primary care transformation and advancing multi-sector collaborations to reduce diabetes disparities in the U.S.
About the Merck Foundation
The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a leading global biopharmaceutical company, the Foundation is funded entirely by the company and is Merck’s chief source of funding support to qualified non-profit charitable organizations. Since its inception, the Merck Foundation has contributed more than $921 million to support important initiatives that address societal needs and are consistent with Merck’s overall mission of inventing for life by bringing forward medicines and vaccines for many of the world’s most challenging diseases.